换一批
换一批Quality of life in adults enrolled in an open-label study of cannabidiol (CBD) for treatment-resistant epilepsy.
第一作者：
Tyler E,Gaston
第一单位：
Department of Neurology, Division of Epilepsy, University of Alabama at Birmingham, Birmingham, AL, USA; UAB Epilepsy Center, University of Alabama at Birmingham, Birmingham, AL, USA; Birmingham VA Medical Center, Birmingham, AL, USA. Electronic address: tegaston@uabmc.edu.
作者：
主题词
成年人(Adult);抗惊厥药(Anticonvulsants);大麻二酚(Cannabidiol);女(雌)性(Female);随访研究(Follow-Up Studies);健康状况指标(Health Status Indicators);人类(Humans);男(雄)性(Male);中年人(Middle Aged);生活质量(Quality of Life);疾病严重程度指数(Severity of Illness Index);治疗结果(Treatment Outcome)
DOI
10.1016/j.yebeh.2019.03.035
PMID
31003195
发布时间
2020-12-10
- 浏览12
Epilepsy & behavior
10-17页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
